IE
NVNO

Israel Englander’s enVVeno Medical NVNO Stock Holding History

Israel Englander’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-304
Closed -$40K – 7367
2022
Q2 		$40K Sell
304
-12
-4% -$1.86K ﹤0.01% 6271
2022
Q1 		$70K Buy
316
+19
+6% +$3.69K ﹤0.01% 6290
2021
Q4 		$69K Sell
297
-14
-5% -$3.94K ﹤0.01% 6388
2021
Q3 		$113K Buy
+311
New +$80.5K ﹤0.01% 6385
2021
Q2 		– Sell
-673
Closed -$157K – 6916
2021
Q1 		$157K Buy
+673
New +$187K ﹤0.01% 5572

Other funds holding NVNO

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AMCA
Arthur M. Cohen & Associates Northbrook, Illinois $640M AUM 26.68% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Israel Englander's NVNO Position: Q3 2022 in Review

Israel Englander sold out of enVVeno Medical (NVNO) in Q3 2022, closing a stake of 304 shares — an estimated $40K sold.

Israel Englander first reported a position in NVNO in Q1 2021 and held it in 5 quarters. The position peaked at $157K in Q1 2021. 22 funds tracked by Wall St. Rank hold NVNO as of Q3 2022.

  • Israel Englander reported no remaining enVVeno Medical position as of Q3 2022 after selling out during the quarter.
  • Israel Englander sold 304 enVVeno Medical shares in Q3 2022, an estimated $40K.
  • Israel Englander first reported a position in enVVeno Medical in Q1 2021 and held it in 5 quarters.
  • Israel Englander's enVVeno Medical position peaked at $157K in Q1 2021.
  • 22 funds tracked by Wall St. Rank held enVVeno Medical as of Q3 2022.

Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.